Back to Business

Hepion Pharmaceuticals director Stetz buys $25,000 in common stock

Business August 13, 2026 at 3:01 AM

Hepion Pharmaceuticals director Stetz buys $25,000 in common stock

Investing.com

Read at Investing.com

More Stories

Anthropic in talks to buy Decart AI, source says

Anthropic in talks to buy Decart AI, source says

🇺🇸 Investing.com 17m ago

This Australian midcap miner is well-exposed to both gold and copper

This Australian midcap miner is well-exposed to both gold and copper

🇺🇸 Investing.com 43m ago

Oil prices drop 1% as weak demand outlook offsets supply uncertainty

Oil prices drop 1% as weak demand outlook offsets supply uncertainty

🇺🇸 Investing.com 1h ago

Your world briefing, in your pocket

AI-curated news from 12 countries and 10 languages — coming soon on iOS and Android.

Coming soon on App Store Coming soon on Google Play